[Clinical characteristics and diagnosis and treatment strategies of patients with severe traumatic aortic injury].

医学 外科 损伤严重程度评分 血肿 毒物控制 伤害预防 环境卫生
作者
Yi-Feng Bu,X Z Liu,Teng Zhou,X D Liu,Haifeng Jin,X J Liu,X Z Wang
出处
期刊:PubMed 卷期号:50 (8): 767-773
标识
DOI:10.3760/cma.j.cn112148-20220430-00333
摘要

Objective: To investigate the clinical characteristics and diagnosis and treatment strategies of patients with severe traumatic aortic injury (TAI). Methods: A total of 25 patients with TAI, who hospitalized in our hospital between August 2005 to March 2021 and underwent thoracic aortic endovascular repair (TEVAR), were included in this retrospective study. According to the time from admission to TEVAR, the patients were divided into emergency TEVAR group (14 cases, TEVAR within 24 h of admission) and elective TEVAR group (11 cases, patients underwent surgery or fracture reduction and fixation first for serious injuries and then underwent TEVAR more than 24 h after admission). The general clinical data of patients, injury severity score (ISS), time from admission to intervention, total hospital stay, the proportion of closed chest drainage and the proportion of abdominal organ repair were obtained and compared. Clinical follow-up and 1-year postoperative aortic computed tomography angiography (CTA) were performed on the patients. Death, the occurrence of aortic adverse events and injury recovery were followed up and recorded. Results: The mean age of these 25 TAI patients was (41.4±14.4) years, 20 patients were males (80.0%). 21 patients (84.0%) had persistent chest and back pain, 17 (68.0%) had pleural effusion and 5 (20.0%) had mediastinal hematoma. The injury severity score (ISS) was significantly higher in the elective TEVAR group than in the emergency TEVAR group (24.9±14.4 vs. 35.5±9.3, P=0.044). The time from admission to intervention ((1.0±0.0) d vs. (3.4±0.9) d, P<0.001], the time from admission to TEVAR ((1.0±0.0) d vs. (11.5±13.8) d, P=0.030) and total hospital stay ((6.1±2.3) d vs. (26.8±7.7) d, P<0.001) were significantly longer in elective TEVAR group than in emergency TEVAR group. The proportion of thoracic closed drainage was significantly lower in the elective TEVAR group than in the emergency TEVAR group (9 (64.3%) vs. 2 (18.2%), P=0.042). The proportion of abdominal organ repair was significantly higher than in the emergency TEVAR group (0 vs. 4 (36.4%), P=0.026). All of 25 patients were discharged alive and followed up for (84.0±30.5) months. All patients survived and completed 1-year postoperation CTA. There were no aortic adverse events occurred, and no complications after surgery, and the fractures and organ injuries healed well. Conclusions: The clinical characteristics of severe TAI are acute multi-injuries combined with persistent chest and/or back pain, pleural effusion, and mediastinal hematoma. Timely diagnosis and treatment are important factors for the outcome. The treatment strategy for multi-injuries should give priority to dealing with life-threatening injuries. TEVAR is the primary treatment strategy for severe TAI and is related to satisfactory outcomes.目的: 探讨严重创伤性主动脉损伤(TAI)患者的临床特征及诊疗策略。 方法: 本研究为回顾性成组病例分析。选取2005年8月至2021年3月于北部战区总医院明确诊断为TAI且行胸主动脉腔内修复术(TEVAR)治疗的25例患者,根据患者入院与TEVAR时间间隔,入院24 h内行TEVAR的患者为急诊TEVAR组(14例),入院先行外科手术或骨折复位固定等处理严重合并伤,24 h后行TEVAR的患者为择期TEVAR组(11例)。收集并比较两组患者的一般临床资料,创伤严重度评分(ISS)、入院与实施干预时间间隔、住院时长、胸腔闭式引流比例、腹部脏器修复比例等。对患者进行临床随访及术后1年主动脉计算机断层扫描血管造影(CTA)影像学随访,记录患者是否死亡、主动脉不良事件发生情况及外伤恢复情况。 结果: 25例TAI患者年龄(41.4±14.4)岁,其中男性20例(80.0%)。21例(84.0%)持续性胸背痛,17例(68.0%)胸腔积液,5例(20.0%)纵隔血肿。与急诊TEVAR组相比,择期TEVAR组ISS更高[(24.9±14.4)分比(35.5±9.3)分,P=0.044],入院与实施干预时间间隔[(1.0±0.0)d比(3.4±0.9)d,P<0.001]、入院与TEVAR时间间隔[(1.0±0.0)d比(11.5±13.8)d,P=0.030]及住院时长[(6.1±2.3)d比(26.8±7.7)d,P<0.001]更长,差异均有统计学意义。与急诊TEVAR组相比,择期TEVAR组接受胸腔闭式引流比例更低[9例(64.3%)比2例(18.2%),P=0.042],接受腹部脏器修复比例更高[0例比4例(36.4%),P=0.026],差异均有统计学意义。25例患者均存活出院,随访(84.0±30.5)个月,患者无死亡,均完成术后1年CTA复查,无主动脉不良事件发生,外科手术未遗留后遗症,骨折及脏器伤愈合良好。 结论: 严重TAI的临床特征为多发急性外伤伴有持续性胸背痛、胸腔积液、纵隔血肿,需及时明确诊断。多发伤处理应选择优先处理危及生命的损伤,严重TAI首选行TEVAR治疗策略,安全可行。.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
细心觅风完成签到,获得积分10
1秒前
mou完成签到,获得积分10
1秒前
2秒前
2秒前
英俊的亦瑶完成签到 ,获得积分10
2秒前
完美栾完成签到,获得积分10
2秒前
科研通AI6.1应助11采纳,获得10
2秒前
奥特曼完成签到,获得积分10
3秒前
木子完成签到,获得积分10
3秒前
3秒前
xingxing完成签到,获得积分10
3秒前
3秒前
闪闪的易文完成签到,获得积分10
4秒前
zhenghua完成签到,获得积分10
4秒前
4秒前
侠侠大王完成签到 ,获得积分10
4秒前
4秒前
隐形曼青应助huangyuchen0910采纳,获得10
5秒前
yanshapo发布了新的文献求助10
5秒前
黄晃晃发布了新的文献求助10
5秒前
Di喵喵完成签到,获得积分10
5秒前
5秒前
Hhl完成签到,获得积分10
5秒前
苗觉觉完成签到,获得积分10
6秒前
6秒前
我绝对不咕完成签到,获得积分10
7秒前
Chow完成签到,获得积分10
7秒前
郝不错发布了新的文献求助10
7秒前
完美栾发布了新的文献求助10
7秒前
xx完成签到,获得积分20
7秒前
7秒前
积极甘蔗完成签到,获得积分10
8秒前
gyj完成签到,获得积分10
8秒前
奋斗的珍完成签到,获得积分10
8秒前
小慧完成签到 ,获得积分10
8秒前
zmh完成签到,获得积分10
9秒前
义气谷兰完成签到,获得积分10
9秒前
请你吃欧润橘完成签到,获得积分10
9秒前
利拉德发布了新的文献求助10
10秒前
xyang2015发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6035060
求助须知:如何正确求助?哪些是违规求助? 7749339
关于积分的说明 16209086
捐赠科研通 5181572
什么是DOI,文献DOI怎么找? 2773093
邀请新用户注册赠送积分活动 1756205
关于科研通互助平台的介绍 1641052